AIGH Capital Management as of Dec. 31, 2025
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 34 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sandisk Corp (SNDK) | 16.1 | $67M | 280k | 237.38 | |
| Zoom Communications Call Call Option | 14.7 | $60M | 700k | 86.29 | |
| Castle Biosciences (CSTL) | 5.9 | $24M | 625k | 38.90 | |
| Personalis Ord (PSNL) | 5.6 | $23M | 2.9M | 7.96 | |
| Nlight (LASR) | 5.5 | $23M | 600k | 37.51 | |
| Day One Biopharmaceuticals I (DAWN) | 4.5 | $19M | 2.0M | 9.32 | |
| Vanda Pharmaceuticals (VNDA) | 4.3 | $18M | 2.0M | 8.82 | |
| Bk Technologies Corporation Com New (BKTI) | 3.8 | $16M | 212k | 74.59 | |
| Domo Com Cl B (DOMO) | 3.8 | $16M | 1.8M | 8.43 | |
| Esperion Therapeutics (ESPR) | 3.6 | $15M | 4.0M | 3.70 | |
| Kyverna Therapeutics (KYTX) | 3.4 | $14M | 1.5M | 9.40 | |
| Fennec Pharmaceuticals (FENC) | 3.0 | $12M | 1.6M | 7.70 | |
| Lightpath Technologies Com Cl A (LPTH) | 2.7 | $11M | 1.0M | 10.80 | |
| Abeona Therapeutics Com New (ABEO) | 2.6 | $11M | 2.0M | 5.27 | |
| Zevra Therapeutics Call Call Option | 2.2 | $9.0M | 1.0M | 8.96 | |
| Intellicheck Com New (IDN) | 2.0 | $8.1M | 1.2M | 6.68 | |
| Larimar Therapeutics (LRMR) | 1.9 | $7.6M | 2.0M | 3.81 | |
| Advanced Emissions (ARQ) | 1.8 | $7.4M | 2.3M | 3.27 | |
| Ardelyx (ARDX) | 1.6 | $6.7M | 1.2M | 5.83 | |
| Byrna Technologies Com New (BYRN) | 1.6 | $6.6M | 395k | 16.79 | |
| Polypid (PYPD) | 1.4 | $5.8M | 1.3M | 4.34 | |
| Coya Therapeutics Common Stock (COYA) | 1.4 | $5.7M | 975k | 5.80 | |
| Seagate Technology Hldngs Call Call Option | 1.3 | $5.5M | 20k | 275.39 | |
| Talphera Com New (TLPH) | 1.3 | $5.3M | 4.7M | 1.14 | |
| Apyx Medical Corporation (APYX) | 0.9 | $3.9M | 1.1M | 3.50 | |
| Acasti Pharma (GRCE) | 0.8 | $3.2M | 907k | 3.49 | |
| Renovorx Com New (RNXT) | 0.6 | $2.4M | 2.8M | 0.84 | |
| Elutia Cl A Com (ELUT) | 0.5 | $2.1M | 3.1M | 0.69 | |
| Neuraxis (NRXS) | 0.4 | $1.8M | 400k | 4.54 | |
| Ideal Pwr Com New (IPWR) | 0.4 | $1.5M | 492k | 3.09 | |
| Smartkem Com New (SMTK) | 0.2 | $719k | 675k | 1.06 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.2 | $712k | 49k | 14.43 | |
| Biofrontera Com New (BFRI) | 0.1 | $522k | 915k | 0.57 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $316k | 371k | 0.85 |
